| INTRODUCTION
Co-infection with the hepatitis C virus (HCV) affects an estimated number of 2.3 million people living with the human immunodeficiency virus (HIV) worldwide, which translates into a co-infection prevalence of 6.2% overall, 6.4% in men who have sex with men, and 82.4% in people who inject drugs. Moreover, viral hepatitis is a leading and increasingly important cause of disability and mortality worldwide, with a doubling of the quality adjusted life years lost because of HCV infection between 1990 and 2013. 1, 2 In HIV-infected patients not receiving combined antiretroviral therapy (cART), HCV co-infection accelerates the development of liver fibrosis compared to HCV mono-infection, 3 and increases the risk for liver-related and non-liver-related causes of death. 4 This progressive liver fibrosis in HCV/HIV infection may be rescued by cART, especially when initiated early after HIV infection before the development of significant immunodeficiency. 5 Mucosal-associated invariant T (MAIT) cells are a group of innatelike T cells that play an important role in the antimicrobial response to a range of bacteria and yeast species. 6, 7 Recently, it has been shown that viral infections, including HCV infection, also activate MAIT-cells in a TCR-independent fashion dependent on cytokines. 8 to produce high levels of IFN-gamma and the cytotoxic enzyme granzyme-B, but also by interaction of the semi-invariant T-cell receptor (TCR) Vα7.2 with the non-polymorphic, major histocompatibility complex class I-related protein 1 (MR1) on antigen presenting cells. 6, 12, 13 MR1 presents riboflavin metabolites synthesized by microbes to the TCR of the MAIT-cell. 14 Viruses do not metabolize riboflavin and were shown to activate MAIT-cells in a TCR-independent fashion dependent on IL-18 in synergy with IL-12, IL-15 and/or type I interferon. 8, 11 Recently, many studies demonstrated that MAIT-cells are depleted from blood of HIV-infected individuals, and express exhaustion markers. Interestingly, their numbers are not fully restored despite effective cART. Recently, we and others demonstrated similar findings for HCVinfected patients. 8, 15, 16 In these patients, MAIT-cells were depleted from peripheral blood, and successful interferon-free therapy was unable to restore their numbers and function, 15, 16 while restoration was observed for impaired CD8 + T cells and NK-cells. [16] [17] [18] The mechanisms underlying MAIT-cell depletion from blood during HIV and HCV infection remain unclear. Activation-induced cell death and accumulation at the site of infection and inflammation, such as the liver in HCV infection, may explain this phenomenon. 8, 15, 16, 19 However, at least for HIV infection this hypothesis seems unlikely, as MAIT-cells were systemically depleted in simian immunodeficiency virus-infected rhesus macaques, a model often used to investigate HIV. 20 Enhanced fibrosis development in HCV/HIV co-infection has been associated with enhanced translocation of gut microbial products in HIV, which drives continuous immune activation. 
| MATERIALS AND METHODS

| Inclusion of patients and healthy subjects
Ethical approval for this study was obtained from the Ethical Review • This study: MAIT-cells are severely depleted in HIV/HCV patients with advanced fibrosis.
• This study: MAIT-cells seem dysfunctional in blood of HCV mono-infected patients.
• This study: There is no evidence for MAIT-cell accumulation in the liver.
T A B L E cART-suppressed HIV mono-infection (n = 9). In addition, blood was collected from healthy volunteers working at Erasmus MC after written informed consent (n = 9). The patient characteristics are presented in Table 1 . Fine needle aspiration biopsies (FNAB) were collected from patients with chronic HCV infection (n = 10) and cART-suppressed HCV/HIV infection (n = 8). The characteristics of these patients are presented in Table 2 .
Liver fibrosis was scored using ultrasound and liver elastography 
| Acquisition of peripheral blood mononuclear cells and liver cells
FNAB for intrahepatic cells were performed as described before. 23, 24 Peripheral blood mononuclear cells (PBMC) were isolated using ficoll separation (Ficoll-Paque™ plus, GE Healthcare Bio-Sciences AB, Uppsala, Sweden). Approximately, 15 million blood lymphocytes were used for analyses and the remainder was frozen at −150°C. 
| Phenotyping by flowcytometry
| Analysis of intracellular cytokines by flowcytometry
The percentages of cells producing IFN-γ and granzyme-B were measured by flowcytometry using various stimuli. For each condition, duplicate wells with 250 000 PBMCs were cultured in a 96 wells plate. 
| Statistics
Flowcytometric data were analysed using Flow Jo TM (TreesTar, windows 7 version 10.0.8). Statistical comparison was performed using the Kruskal-Wallis and Mann-Whitney test for unpaired nonparametric analyses. A P value ≤ .05 was considered significant.
| RESULTS
| MAIT-cells are severely depleted in blood of HCV, HIV and HCV/HIV patients
It has been reported that MAIT-cells are depleted in blood of HIV and HCV patients. 8, 11, 15, 16, 19, [25] [26] [27] [28] [29] [30] We confirmed these findings by perform- ( Figure 3B ). Also for NK-cells, no significant differences were observed when comparing the patients with different fibrosis scores.
| Reduced function of MAIT-cells in blood of HCV mono-infected patients with severe fibrosis and cirrhosis vs no to mild fibrosis
To determine whether fibrosis scores affected the functionality of MAIT-cells in these patients, PBMC were stimulated as before. As Figure 3A , is not reflected by higher frequencies in the liver of this population in the same patient.
| Ex vivo intrahepatic MAIT-cells do not differ in frequency in HCV mono-infected vs HCV/HIV patients
| DISCUSSION
In line with an increasing number of studies, we confirmed that the To rule out that our experimental set-up was responsible for our findings, we repeated our MAIT IFN-γ production experiments on identical samples using an optimized protocol recently published by Dias and colleagues. 31 Blood Liver of healthy individuals. 21, 22 It is important to examine in future studies whether patient cohorts and/or methodological factors account for these differences in frequencies. More studies are also needed to in- In conclusion, our findings demonstrate that the degree of impairment of the MAIT-cell compartment in blood of HCV and HCV/HIV patients is more pronounced in individuals with severe liver fibrosis or cirrhosis as compared to those without or with only mild fibrosis.
Moreover, evaluation of aspirate biopsies of the liver provided no evidence for enhanced MAIT-cell migration to the liver during chronic viral infections or advanced fibrosis.
